About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

European Union-Funded Project to Engineer Bacteria for Novel Vaccines

by Bidita Debnath on May 11, 2015 at 1:38 AM
Font : A-A+

European Union-Funded Project to Engineer Bacteria for Novel Vaccines

A European Union-funded project is combining biotechnology and gene engineering to design novel vaccines based on the bacterium Mycoplasma pneumoniae.

The Mycosplasma bacteria are the smallest self-replicating organisms.

Advertisement

They lack a cell wall, making them resistant to almost all antibiotics, and infections caused by Mycoplasma in livestock, result in huge losses in Europe and throughout the world.

Although there are vaccines against two species of Mycoplasma that affect pigs and poultry, no vaccines exist for many Mycoplasma species that affect not only livestock but also pets and humans.
Advertisement

The eight-million Euro MycoSynVac project will see researchers engineer a universal vaccine chassis that will be free of virulence and optimized for fast growth in a serum-free medium.

This chassis will be used to create specific vaccines against two highly detrimental pathogens that are causing suffering in livestock animals and large financial losses to the animal industry.

The chassis will also set the basis for other potential applications, such as for cell therapy and infectious lung disease treatment.

"We will engineer a new bacteria to be used as a vaccine. We will remove the genes that make the bacteria pathogenic and improve the chassis for an optimized growth in a serum-free medium," said Luis Serrano, director of the Centre for Genomic Regulation (CRG) and co-coordinator of the project.

By expressing specific harmless antigens from one or more pathogens, we will be able to create targeted vector vaccines, he said.

Researchers also foresee that the generated mycoplasma chassis can be further developed for other vaccines and will have other potential applications, such as in cell therapy and infectious lung disease therapy.

Source: IANS
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Ways to Manage Stress during COVID-19 Pandemic
Can Adjusting Fatty Acid Intake Improve Mood in Bipolar Disorder Patients?
Insulin Resistance Doubles the Risk of Major Depressive Disorder
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Shigellosis MRSA - The Super Bug Vaccination for Children Food Safety for Health Antibiotics 

Recommended Reading
WHO: Nine Million Infants in Southeast Asia Do Not Get Basic Vaccines
India is one of the countries with less than 80% immunization coverage. Out of 38,000 kids that die ...
Clinical Trials for Two Ebola Vaccines Show No Adverse Reactions in Monkeys
There are other vaccines against Ebola that are already in human trials but they have reported side ...
Fall in Swine Flu Cases in Kashmir, Vaccines Remain Unused
Around 2,500 swine flu vaccines have been left unused because people are unwilling to get ......
China Agrees to Supply More Japanese Encephalitis Vaccines to India
China had earlier refused to supply more vaccines to India, citing capacity constraints and ......
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general featu...
MRSA - The Super Bug
MRSA infection is the most dreaded hospital or community acquired infection that can become ......
Shigellosis
Shigellosis or Bacillary Dysentery is a common cause of gastro-enteritis worldwide and can cause blo...
Vaccination for Children
Vaccines are biological products that impart immunity to the recipient. Vaccines may be live attenua...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use